Hints and tips:
Related Special Reports
...Eli Lilly has made cuts in Europe and reduced the number of clinical trials there, he added. But some campaigners for access to medicines welcomed the proposals....
...This month, the chief executive of Eli Lilly, one of the world’s biggest pharma groups, warned that Europe could miss out on new drugs for conditions such as heart disease and cancer if it pushes ahead with...
...Lilly has invested billions of dollars to grow production capacity for its weight-loss treatments across sites in Germany, North Carolina and its home state of Indiana but Ricks said the company was a “long...
...Suzhou-based biotech group Innovent has the Chinese rights to a promising next generation obesity drug from Eli Lilly called Mazdutide. It announced positive late-stage trial results in January....
...Drugmakers Novo Nordisk and Eli Lilly are facing a possible wave of personal injury lawsuits over claims they failed to warn patients their blockbuster diabetes and weight-loss drugs can cause stomach paralysis...
...Dozens of multinationals manufacturers such as PepsiCo and Eli Lilly have complied with the Programme HQ edict....
...Obesity drugs: Weight-loss treatments are tipped to rake in $80bn a year by 2030, but smaller companies will struggle to break into a market led by Novo Nordisk and Eli Lilly....
...Eli Lilly is racing to secure the services of outsourcers to boost production of its obesity drug Zepbound, as the US pharmaceutical group rolls out its rival to Danish group Novo Nordisk’s blockbuster appetite...
...Other earnings: Eli Lilly, ConocoPhillips, Moderna, Molson Coors, Fox, Shopify and Paramount Global will report before the market opens....
...Here’s what else I’m keeping tabs on today: Results: Eli Lilly, the maker of weight loss drug Mounjaro, reports this morning alongside KKR, Spotify, GE Healthcare and Hertz....
...The 70 per cent price cuts on injectable versions of the drug Humalog and Humlin will be implemented in the fourth quarter while the prices of one of the company’s non-branded insulin products will take...
...Other drugmakers could still “win” the race in the rapidly growing obesity market dominated by Novo Nordisk and Eli Lilly, according to the chief executive of biotech company Zealand Pharma....
...“It will be many years until we know the final tally . . . and can intelligently make decisions about the desirability of future investments in vulnerable western states,” Buffett wrote....
...Today, Eli Lilly is heeding my call. Others should follow,” he wrote on Twitter....
...The US Food and Drug Administration delayed an approval decision on Eli Lilly’s breakthrough Alzheimer’s disease drug, which was expected to be approved this month....
...Tiger’s winning bets included Meta and other tech giants Microsoft, Amazon and Google. Its non-tech winners included Apollo Global, Eli Lilly, Airbus and online gambling company Flutter....
...News round-up India’s business elite sounds alarm over Rolex thefts in London’s Mayfair (FT) Eli Lilly calls for scrutiny of rival Novo Nordisk’s $11bn deal production deal (FT) Canary Wharf office takes...
...Novo Nordisk and Eli Lilly have a new challenger in weight-loss drugs: Danish biotech Zealand Pharma. Goldman Sachs says the market could grow from $6bn to as much as $100bn by the end of the decade....
...The success of weight loss drugs from Novo Nordisk and Eli Lilly has prompted other invidious comparisons. Roche is therefore acquiring US-based obesity drugs developer Carmot for up to $3.1bn....
...Danish pioneer Novo Nordisk and rival Eli Lilly have made the running in weight-loss drugs but about a dozen companies are set to announce trial results for more than 20 drugs this year....
...The initial list of 10 drugs to face price negotiations includes a diabetes pill called Jardiance sold by Boehringer Ingelheim and Eli Lilly; a medicine to prevent strokes called Eliquis made by Pfizer and...
...Jamie SmythSo this new generation of weight loss drugs are made by the Danish company Novo Nordisk and US drugmaker Eli Lilly. They were actually first developed to treat diabetes....
...Results: Apple, Eli Lilly, ConocoPhillips, Fox, Starbucks, S&P Global, Moderna, Shopify and Paramount Global will report before the market opens....
...Tobey is adviser to many Fortune 500 companies including CVS, 3M and Eli Lilly, and regularly speaks to a range of organisations on the risks and benefits of AI....
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
International Edition